Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products.
The company possesses a narrow moat derived from its parent company's (Sumitomo Chemical Japan) proprietary R&D pipeline and a robust domestic distribution network. This is corroborated by high ROCE (25.1%) and the ability to maintain gross margins above 40% even during severe industry downturns and climatic volatility.
Management maintains a debt-free balance sheet while funding capacity expansions at Bhavnagar, Tarapur, and the upcoming Dahej greenfield site entirely through internal accruals. They demonstrate discipline by prioritizing margin integrity over volume dumping and have successfully integrated the Barrix acquisition to turn it profitable.
The investment collapsed as the parent company shifted from a supportive partner to a value-extractor, implementing aggressive royalty structures that eroded the domestic subsidiary's margins. Simultaneously, the heavy reliance on a proprietary R&D pipeline from Japan proved a double-edged sword when global agrochemical shifts toward biologicals and off-patent generics rendered their high-cost specialty portfolio obsolete. The massive capital expenditure at Dahej, funded by internal accruals, became a stranded asset as inventory buildup turned into permanent write-downs, and the distribution network failed to protect pricing power against a flood of low-cost competitors.
RichFakir rates Sumitomo Chemical India Ltd's business quality as wonderful — 76/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Sumitomo Chemical India Ltd is trading about 80% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Sumitomo Chemical India Ltd is: Watch — wait for price. A wonderful business, but at an expensive price against our estimate of fair value — one to keep on the watchlist for a better entry.
RichFakir's educational estimate of Sumitomo Chemical India Ltd's fair value is about ₹175 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →